Discontinued — last reported Q3 '16
Intuit Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) remained flat by 0.0% to $590.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $581.00M to $590.00M. Over 4 years (FY 2021 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows an upward trend with a 24.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $247.00M | $247.00M | $620.00M | $620.00M | $594.00M | $594.00M | $594.00M | $581.00M | $581.00M | $581.00M | $581.00M | $581.00M | $581.00M | $590.00M | $590.00M |
| QoQ Change | — | +0.0% | +151.0% | +0.0% | -4.2% | +0.0% | +0.0% | -2.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +1.5% | +0.0% |
| YoY Change | — | — | — | +151.0% | +140.5% | -4.2% | -4.2% | -2.2% | -2.2% | -2.2% | +0.0% | +0.0% | +0.0% | +1.5% | +1.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.